About the Journal

Hematological Disorders in the Single-Cell Era (HDSCE) is an international, interdisciplinary open-access journal dedicated to advancing the integration of single-cell technologies with the research, diagnosis, and treatment of hematological diseases. By emphasizing the transformative potential of high-resolution molecular profiling in understanding blood disorders, HDSCE serves as a premier scholarly forum for disseminating cutting-edge research across single-cell genomics, transcriptomics, proteomics, and multi-omics integration in hematopoiesis, leukemia, lymphoma, anemia, and clotting disorders. The journal bridges hematology, oncology, immunology, computational biology, and biomedical engineering to accelerate the transition toward precision medicine in blood-related diseases.

HDSCE seeks to illuminate the interdisciplinary connections between single-cell biology and clinical hematology, addressing complex challenges at the intersection of molecular heterogeneity, disease mechanisms, and therapeutic innovation. 
HDSCE prioritizes translational research and case studies that demonstrate scalable solutions for next-generation hematology, including but not limited to:
・Single-Cell Genomics & Clonal Evolution
・Leukemia & Lymphoma Heterogeneity
・Stem Cell Biology & Hematopoiesis
・Computational Hematology & AI-Driven Diagnostics
・Immunotherapy & CAR-T Cell Engineering
・Non-Invasive Liquid Biopsy Approaches
・Ethical & Regulatory Challenges in Single-Cell Medicine